Deborah Proctor

Deborah Proctor, MD, is a Professor of Medicine (Digestive Diseases) at Yale School of Medicine and Medical Director of the Inflammatory Bowel Disease (IBD) Program. She specializes in treating patients with IBD and Hereditary Hemorrhagic Telangiectasia (HHT) at multiple Yale-affiliated locations, including Yale-New Haven Hospital. Her IBD Program offers multidisciplinary care, specialized nursing, and research opportunities in mood disorders, treatment protocols, and drug trials.

• Education: MD (University of Cincinnati, 1982), BS (University of Toledo, 1978)
• Training: Fellowship & Residency (Beth Israel Hospital, Harvard Medical School, 1990-1992)

Her research focuses on IBD clinical outcomes, including histologic healing, colonoscopy protocols, and the psychological impact of chronic gastrointestinal conditions. She collaborates on multi-center drug trials and global health initiatives.

Recent publications highlight trends in IBD management, gastrointestinal oncology, and the intersection of sleep disorders with IBD. She contributes to medical education and clinical training evaluation for gastroenterology fellows.

• Awards: 2023 William J. Pomfret Veteran Community Service Award, Best Doctors in America (2019-2021), Distinguished Educator Award (2019)

Proctor leads the Honduras Children's Project and serves as Site Director for the Yale/Stanford Johnson & Johnson Global Health Scholar Program. She is a sub-investigator in the OPTIMIZE Trial (HIC ID 2000032294) focused on IBD treatment optimization.